10x Genomics (TXG)
(Delayed Data from NSDQ)
$13.13 USD
-0.22 (-1.65%)
Updated Sep 16, 2025 04:00 PM ET
After-Market: $13.12 -0.01 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth F Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, 10x Genomics has a market cap of $1.66B, which represents its share price of $13.35 multiplied by its outstanding shares number of 124.49M. As a small-cap company, TXG's shareholders are generally exposed to more risk than shareholders of mid and large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
TXG 13.13 -0.22(-1.65%)
Will TXG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for TXG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for TXG
TEM Q2 Revenues Soar Amid Coverage Issues: Time to Buy, Hold or Sell?
Zacks.com featured highlights include Tsakos Energy Navigation Limited, 10x Genomics, Pan American Silver, Wolverine World Wide and Interface
TXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
5 Must-Buy Efficient Stocks to Buy Amid Volatile Market Conditions
10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates
Other News for TXG
Is TXG preparing to trend higher? Crossed Above 50 Day Moving Average shows up after soaring 5.62%
10x Genomics: Surprise Profitability May Be Temporary, But It's Still A Welcome Sign
Is TXG lining up for a decline? MACD Bearish Centerline Cross shows up after sinking 3.22%
Pocket Pivot appears for TXG after 3.73% move
TXG forms 20 Day Moving Average Resistance on September 10